Page last updated: 2024-08-23

pirfenidone and prednisolone

pirfenidone has been researched along with prednisolone in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (25.00)29.6817
2010's5 (62.50)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Azuma, A1
Arimura, A; Hikita, I; Kawabata, T; Matsushima, S; Nagira, M; Oku, H; Shimizu, T; Torii, M; Ueyama, A1
Bajwah, S; Higginson, IJ; Koffman, J; Patel, AS; Peacock, JL; Riley, J; Ross, JR; Wells, AU1
Kunii, E; Moriyama, S; Niimi, A; Ohkubo, H1
Kamali, Y; Mandegary, A; Nabipour, F; Pourgholamhosein, F; Rasooli, R1
Homma, S; Kabuki, T; Shibuya, K; Sugino, K1
Behera, D; Deep, A; Gupta, S; Padhan, P; Priyadarshini, S; Singh, P1

Reviews

2 review(s) available for pirfenidone and prednisolone

ArticleYear
[Newly developed therapeutic drugs for idiopathic interstitial pneumonias].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2006, Jun-10, Volume: 95, Issue:6

    Topics: Acetylcysteine; Drug Design; Drug Therapy, Combination; Humans; Interferon-gamma; Lung Diseases, Interstitial; Prednisolone; Pyridones; Randomized Controlled Trials as Topic

2006
Interventions to improve symptoms and quality of life of patients with fibrotic interstitial lung disease: a systematic review of the literature.
    Thorax, 2013, Volume: 68, Issue:9

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Cough; Dyspnea; Exercise Test; Fibrosis; Glucocorticoids; Heroin; Humans; Immunologic Factors; Lung; Lung Diseases, Interstitial; Narcotics; Oxygen Inhalation Therapy; Piperazines; Prednisolone; Purines; Pyridones; Quality of Life; Sildenafil Citrate; Sulfones; Thalidomide; Tubulin Modulators

2013

Other Studies

6 other study(ies) available for pirfenidone and prednisolone

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis.
    European journal of pharmacology, 2008, Aug-20, Volume: 590, Issue:1-3

    Topics: Animals; Bleomycin; Chemokines; Cytokines; Dose-Response Relationship, Drug; Fibroblast Growth Factor 2; Intercellular Signaling Peptides and Proteins; Interferon-gamma; Interleukin-12 Subunit p40; Lung; Male; Mice; Mice, Inbred ICR; Prednisolone; Pulmonary Fibrosis; Pyridones; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha

2008
Efficacy of combined corticosteroid and pirfenidone for acute exacerbation of idiopathic pulmonary fibrosis after surgery for lung cancer: a case report.
    Respiratory investigation, 2015, Volume: 53, Issue:1

    Topics: Acute-Phase Reaction; Aged, 80 and over; Disease Progression; Drug Therapy, Combination; Glucocorticoids; Humans; Idiopathic Pulmonary Fibrosis; Infusions, Intravenous; Lung Neoplasms; Male; Methylprednisolone; Postoperative Complications; Prednisolone; Pulse Therapy, Drug; Pyridones; Treatment Outcome

2015
Combination Therapy with Pirfenidone plus Prednisolone Ameliorates Paraquat-Induced Pulmonary Fibrosis.
    Inflammation, 2018, Volume: 41, Issue:1

    Topics: Animals; Anti-Inflammatory Agents; Cytoprotection; Disease Models, Animal; Drug Therapy, Combination; Gene Expression Regulation; Glucocorticoids; Hydroxyproline; Inflammation Mediators; Lung; Male; Matrix Metalloproteinase 2; Oxidative Stress; Paraquat; Prednisolone; Pulmonary Fibrosis; Pyridones; Rats, Sprague-Dawley; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha

2018
Systemic scleroderma-related interstitial pneumonia associated with borderline pulmonary arterial hypertension.
    BMJ case reports, 2018, May-26, Volume: 2018

    Topics: Aged; Anti-Inflammatory Agents; Drug Therapy, Combination; Endothelin A Receptor Antagonists; Female; Humans; Hypertension, Pulmonary; Lung Diseases, Interstitial; Prednisolone; Pulmonary Artery; Pyridones; Pyrimidines; Scleroderma, Limited; Sulfonamides

2018
Nintedanib vs pirfenidone in the management of COVID-19 lung fibrosis: A single-centre study.
    The journal of the Royal College of Physicians of Edinburgh, 2022, Volume: 52, Issue:2

    Topics: Adult; C-Reactive Protein; COVID-19 Drug Treatment; Ferritins; Humans; Idiopathic Pulmonary Fibrosis; Indoles; Middle Aged; Prednisolone; Pyridones; Treatment Outcome

2022